Abstract
Although we are beginning to develop treatment options for malignant melanoma, earlier recognition of potential primary melanomas remains the most effective way to increase survival in this highly malignant disease. This article reviews prominent risk factors for melanoma, key physical findings in at-risk patients, new melanoma staging guidelines, and recent and emerging therapy options.
MeSH terms
-
Adult
-
Dysplastic Nevus Syndrome / diagnosis
-
Female
-
Heliotherapy / adverse effects
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use
-
Male
-
Melanoma / diagnosis*
-
Melanoma / etiology
-
Melanoma / pathology
-
Melanoma / secondary
-
Melanoma / therapy*
-
Middle Aged
-
Neoplasm Staging
-
Precancerous Conditions / diagnosis
-
Recombinant Proteins
-
Risk Factors
-
Skin Neoplasms / diagnosis*
-
Skin Neoplasms / etiology
-
Skin Neoplasms / pathology
-
Skin Neoplasms / therapy*
-
Ultraviolet Rays / adverse effects
Substances
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins